LONDON (Reuters) - GlaxoSmithKline's experimental once-weekly diabetes drug albiglutide was effective in late-stage clinical trials, but the medicine may struggle to differentiate itself in an increasingly competitive market. Albiglutide belon...
Source: http://health.yahoo.net/news/s/nm/new-gsk-diabetes-drug-works-but-faces-tough-competition
found it for you found it I found it found here
No comments:
Post a Comment
Note: only a member of this blog may post a comment.